Literature DB >> 30996800

EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues.

Maria Novella Romanelli1, Martina Del Lungo1, Luca Guandalini1, Mehrnoush Zobeiri2, András Gyökeres3, Tamás Árpádffy-Lovas3, Istvan Koncz3, Laura Sartiani1, Gianluca Bartolucci1, Silvia Dei1, Dina Manetti1, Elisabetta Teodori1, Thomas Budde2, Elisabetta Cerbai1.   

Abstract

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are membrane proteins encoded by four genes (HCN1-4) and widely distributed in the central and peripheral nervous system and in the heart. HCN channels are involved in several physiological functions, including the generation of rhythmic activity, and are considered important drug targets if compounds with isoform selectivity are developed. At present, however, few compounds are known, which are able to discriminate among HCN channel isoforms. The inclusion of the three-methylene chain of zatebradine into a cyclohexane ring gave a compound (3a) showing a 5-fold preference for HCN4 channels, and ability to selectively modulate Ih in different tissues. Compound 3a has been tested for its ability to reduce Ih and to interact with other ion channels in the heart and the central nervous system. Its preference for HCN4 channels makes this compound useful to elucidate the contribution of this isoform in the physiological and pathological processes involving hyperpolarization-activated current.

Entities:  

Year:  2019        PMID: 30996800      PMCID: PMC6466822          DOI: 10.1021/acsmedchemlett.8b00587

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  37 in total

1.  Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis.

Authors:  R Seifert; A Scholten; R Gauss; A Mincheva; P Lichter; U B Kaupp
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  HCN channels are expressed differentially in retinal bipolar cells and concentrated at synaptic terminals.

Authors:  Frank Müller; Alexander Scholten; Elena Ivanova; Silke Haverkamp; Elisabeth Kremmer; U Benjamin Kaupp
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

3.  Immunohistochemical localization of Ih channel subunits, HCN1-4, in the rat brain.

Authors:  Takuya Notomi; Ryuichi Shigemoto
Journal:  J Comp Neurol       Date:  2004-04-05       Impact factor: 3.215

4.  Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current.

Authors:  Maria Novella Romanelli; Elisabetta Cerbai; Silvia Dei; Luca Guandalini; Cecilia Martelli; Elisabetta Martini; Serena Scapecchi; Elisabetta Teodori; Alessandro Mugelli
Journal:  Bioorg Med Chem       Date:  2005-02-15       Impact factor: 3.641

Review 5.  HCN channels: structure, cellular regulation and physiological function.

Authors:  C Wahl-Schott; M Biel
Journal:  Cell Mol Life Sci       Date:  2009-02       Impact factor: 9.261

6.  Bradycardic and proarrhythmic properties of sinus node inhibitors.

Authors:  Juliane Stieber; Karen Wieland; Georg Stöckl; Andreas Ludwig; Franz Hofmann
Journal:  Mol Pharmacol       Date:  2005-12-30       Impact factor: 4.436

7.  Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain.

Authors:  Sandra R Chaplan; Hong-Qing Guo; Doo Hyun Lee; Lin Luo; Changlu Liu; Chester Kuei; Alexander A Velumian; Matthew P Butler; Sean M Brown; Adrienne E Dubin
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

8.  Different Types of Potassium Outward Current in Relay Neurons Acutely Isolated from the Rat Lateral Geniculate Nucleus.

Authors:  Thomas Budde; Ralph Mager; Hans-Christian Pape
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

9.  Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2.

Authors:  Andreas Ludwig; Thomas Budde; Juliane Stieber; Sven Moosmang; Christian Wahl; Knut Holthoff; Anke Langebartels; Carsten Wotjak; Thomas Munsch; Xiangang Zong; Susanne Feil; Robert Feil; Marike Lancel; Kenneth R Chien; Arthur Konnerth; Hans-Christian Pape; Martin Biel; Franz Hofmann
Journal:  EMBO J       Date:  2003-01-15       Impact factor: 11.598

Review 10.  Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

Authors:  S Sulfi; A D Timmis
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

View more
  3 in total

1.  The hyperpolarization-activated cyclic nucleotide-gated 4 channel as a potential anti-seizure drug target.

Authors:  Qays Kharouf; A Marie Phillips; Lauren E Bleakley; Emma Morrisroe; Julia Oyrer; Linghan Jia; Andreas Ludwig; Liang Jin; Joseph A Nicolazzo; Elisabetta Cerbai; M Novella Romanelli; Steven Petrou; Christopher A Reid
Journal:  Br J Pharmacol       Date:  2020-06-17       Impact factor: 8.739

2.  Modulation of pacemaker channel function in a model of thalamocortical hyperexcitability by demyelination and cytokines.

Authors:  Rahul Chaudhary; Stefanie Albrecht; Maia Datunashvili; Manuela Cerina; Annika Lüttjohann; Ye Han; Venu Narayanan; Dane M Chetkovich; Tobias Ruck; Tanja Kuhlmann; Hans-Christian Pape; Sven G Meuth; Mehrnoush Zobeiri; Thomas Budde
Journal:  Cereb Cortex       Date:  2022-10-08       Impact factor: 4.861

3.  Systemic administration of ivabradine, a hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, blocks spontaneous absence seizures.

Authors:  Yasmine Iacone; Tatiana P Morais; François David; Francis Delicata; Joanna Sandle; Timea Raffai; Harri Rheinallt Parri; Johan Juhl Weisser; Christoffer Bundgaard; Ib Vestergaard Klewe; Gábor Tamás; Morten Skøtt Thomsen; Vincenzo Crunelli; Magor L Lőrincz
Journal:  Epilepsia       Date:  2021-05-20       Impact factor: 6.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.